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MitochondriaApoptosis in neuronal tissue is an efﬁcient mechanism which contributes to both normal cell development and
pathological cell death. The present study explores the effects of extracellular ADP on low [K+]-induced apoptosis
in rat cerebellar granule cells. ADP, released into the extracellular space in brain by multiple mechanisms, can
interactwith its receptor or be converted, through the actions of ectoenzymes, to adenosine. The ﬁndings reported
in this paper demonstrate that ADP inhibits the proapoptotic stimulus supposedly via: i) inhibition of ROS produc-
tion during early stages of apoptosis, an effect mediated by its interaction with cell receptor/s. This conclusion is
validated by the increase in SOD and catalase activities aswell as by theGSSG/GSH ratio value decrease, in conjunc-
tion with the drop of ROS level and the prevention of the ADP protective effect by pyridoxalphosphate-6-
azophenyl-2′,4′-disulfonic acid (PPADS), a novel functionally selective antagonist of purine receptor; ii) safeguard
of the functionality of the mitochondrial adenine nucleotide-1 translocator (ANT-1), which is early impaired
during apoptosis. This effect is mediated by its plausible internalization into cell occurring as such or after its
hydrolysis, by means of plasma membrane nucleotide metabolizing enzymes, and resynthesis into the cell.
Moreover, the ﬁndings that ADP also protects ANT-1 from the toxic action of the twoAlzheimer's disease peptides,
i.e. Aβ1–42 andNH2htau,which are known to be produced in apoptotic cerebellar neurons, further corroborate the
molecular mechanism of neuroprotection by ADP, herein proposed.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
ATP is abundantly present in the central nervous system(CNS) [1] and
is released into the extracellular space in response to stimulation-
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39 080 5443317.balance between its release and removal by means of ectonucleotidase-
dependent degradation [3], which results in the generation of ADP and
adenosine (ADO), two molecules that, acting at a level of cell membrane
surface via purine-receptors [4–8], play a pivotal role in cell differentia-
tion, growth and death affecting the development and the vital functions
of different organs and apparatus [6,9–14].
It has been previously reported that when cerebellar granule cells
(CGCs) are shifted to lethal conditions, i.e. exposed to a culture medium
containing a low,more physiological, K+ concentration (5mM) [for refs
see 15–17], in the presence of various purine receptor antagonists, 100
and 80% of neurons survived after 24 and 48 h [18], respectively. The
antiapoptotic action of these molecules could be likely achieved via ac-
tivation of the cellular antioxidant (AOX) system through the interac-
tion of these ligands with their receptors in cultured cells [19,20].
Consistently, Suzuki's group [21] demonstrated that extracellular ATP
has a preventive action on apoptotic cell death in differentiated PC12
cells, mainly via the activation of P2X2 receptors.
Taking advantage of the availability of a cell system, namely CGCs, in
which the main apoptotic steps have been well characterized from a
temporal and causative point of view [for refs see 17], we validated
once for all the hypothesis that the antiapoptotic action of ADP is real-
ized via activation of the AOX system, as suggested by the increase of
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ratio value. Furthermore and for the ﬁrst time, we demonstrated that
extracellular ADP, after being internalized into the cells, prevents the
impairment of the mitochondrial ANT-1 [see 17], a key protein in the
death route, and rescues cells from death. Moreover, the ability of ADP
to protect ANT-1 from the toxic action of the two Alzheimer's disease
(AD) peptides, i.e. Aβ1–42 and NH2htau, was also checked. On the
assumption that neuropathies are the result of neuronal apoptosis, the
identiﬁcation of compounds that, like ADP, are able to protect neurons
against apoptosis is highly desirable.
2. Materials and methods
2.1. Ethics statements
This studywas performed in accordancewith local ethics committee
and with the principles contained in the Declaration of Helsinki as re-
vised in 1996. All animals were handled and cared for in accordance
with EEC guidelines (Directive 86/609/CEE). The animals were anesthe-
tized and insensitive to pain throughout the procedure.
2.2. Reagents
Tissue culture medium and fetal calf serum were purchased from
Gibco (Grand Island, NY, USA) and tissue culture dishes were from
NUNC (Taastrup, Denmark). The antagonist of purine receptor
(pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid, PPADS), the in-
hibitor of ectonucleotidase (α,β-methylene-adenosine-5′-diphosphate,
AMPCP), the inhibitor of nucleoside transporter (S-(4-Nitrobenzyl)-6-
thioinosine, NBMPR) and all other enzymes and biochemicals were
from Sigma Chemical Co. (St Louis, MO, USA). The inhibitor z-VAD-
fmk was purchased from Calbiochem (La Jolla, CA, USA). Fibrillar
Aβ1–42 (Sigma Chemical Co., St. Louis, MO, USA) – sometimes called,
for simplicity, Aβ – was prepared according to Eckert et al. [22] with
minor modiﬁcations. The peptide was dissolved in deionized water at
a concentration of 0.5 mM and stored at −20 °C. At occurrence, the
stock solution was diluted in phosphate buffered saline (PBS) to a con-
centration of 0.1 mM and incubated at 37 °C, with gentle agitation, for
24 h to obtain aged, aggregated preparations of Aβ1–42. Synthetic
NH2-tau peptide, i.e. NH226–44 was synthesized by Sigma Genosys
(Haverhill, UK), and puriﬁed to N95% homogeneity by reversed-phase
high pressure liquid chromatography on C-18 silica columns with
monitoring of A214 (peptide bonds).
2.3. Cell cultures
Primary cultures of CGCs were obtained from dissociated cerebellar
of 7-day-old Wistar rats as in Levi et al. [23]. Cells were plated in basal
medium Eagle (BME) supplemented with 10% fetal calf serum, 25 mM
KCl, 2 mM glutamine and 100 μg/ml gentamicin on dishes coated with
poly-L-lysine. Arabinofuranosylcytosine (10 μM) was added to the
culture medium 18–22 h after plating to prevent proliferation of non-
neuronal cells.
2.4. Induction of apoptosis
Apoptosis was induced at 6–7 days in vitro (DIV): cells were
washed and switched to a serum-free BME, containing 5 mM KCl
and supplemented with 2 mM glutamine and 100 μg/ml gentamicin
for the indicated times [15]. Apoptotic cells are referred to as S-K5 cells
or as x-time-S-K5 to indicate the different ‘x’ time after apoptosis induc-
tion at which the cells are processed. In some experiments ADP (1mM)
was also added, at the indicated times, with exposure terminated by
removal of the compound-containing medium, double washing of the
cell layer and replacement with fresh media. Sister cultures prepared
under the same conditions were used in each experiment. Controlcells were treated identically but maintained in serum-free BME medi-
um supplemented with 25 mM KCl for the indicated times; they are
referred to as S-K25 cells. The occurrence of apoptosis was checked, as
in [15,24], by measuring DNA laddering and prevention of death due
to the addition of the transcriptional inhibitor actinomycin D (Act D).
2.5. Cell homogenate and mitochondria preparations
The culturemediumwas removed and the plated CGCswere repeat-
edly washed with phosphate-buffered saline (PBS), containing 138mM
NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 15 mM KH2PO4 pH 7.4, and then
collected. Cell integrity was quantitatively assessed by the inability of
cells to oxidize externally added succinate, and by the ability of ouabain
to block glucose transport [25]. Cell homogenatewas obtained froma cell
suspension by 10 strokes with a Dounce homogenizer at room temper-
ature. Cytosolic lactate dehydrogenase was released and subsequent
treatment with Triton-X-100 did not cause further release. The func-
tionality of themitochondria was checked for their coupling bymeasur-
ing the respiratory control index, i.e. (oxygen uptake rate after ADP
addition) / (oxygen uptake rate before ADP addition) which reﬂects
the ability of the mitochondria to produce ATP, and for their intactness
by measuring in the post-mitochondrial supernatant the activities of
adenylate kinase (ADK, E.C.2.7.4.3) and glutamate dehydrogenase
(GDH, E.C.1.4.1.3), which are marker enzymes of the mitochondrial
intermembrane space and matrix, respectively. The ADK reaction was
assayed, essentially as in [17,24], at 25 °C and pH 7.2 to mimic intracel-
lular pH in a standard coupled spectrophotometric assay, in which the
ADK-catalyzed synthesis of ATP from ADP was measured by using
glucose (2.5 mM), hexokinase (HK, 0.5 e.u.), glucose-6-phosphate
dehydrogenase (G-6-PDH, 0.5 e.u.) and NADP+ (0.2 mM). To prevent
any ATP production via oxidative phosphorylation, 10 μg oligomycin
and 20 μM ATR were also present to completely inhibit ATP synthase
and ANT respectively. When determining the GDH activity at 25 °C
the following substrates were used: 10 mM 2-oxoglutarate, 10 mM
NH4Cl and 0.2 mM NADH; the NADH oxidation was photometrically
monitored at 340 nm as a function of time. Protein content was
determined, according to [26], with bovine serum albumin used as a
standard.
2.6. Assessment of neuronal viability
Viable CGCswere quantiﬁed by counting the number of intact nuclei
in a hemocytometer, after lysing the cells in detergent-containing solu-
tion [27]. Cell counts were performed in triplicate and are reported as
means ± standard deviation (SD). The data are expressed as the
percentage of intact nuclei in the control cultures at each time point.
Apoptosis was expressed as the percentage of intact cells with respect
to control cells (%C) kept under the same respective experimental con-
ditions. In control experiments 95–97% integritywas found after 24 h. In
some experiments, a variety of compounds (including the inhibitors of
ectonucleotidases, purine receptor and ADO transporter) were added
at the induction time at the concentrations selected to avoid any possi-
ble interference with cell viability.
2.7. DNA fragmentation analysis
Fragmentation of DNA was performed as in [27]. Brieﬂy CGCs (6 ×
106) were plated in poly-L-lysine-coated 60 mm tissue culture dishes
and collected with cold phosphate-buffered saline (PBS pH 7.2). After
removal of the medium and washing once with cold PBS, CGCs were
centrifuged at 3500 ×g for 5 min. The pellet was lysed in 10 mM Tris–
HCl, 10 mM EDTA and 0.2% Triton X-100 (pH 7.5). After 30 min on ice,
the lysates was centrifuged at 17,000 ×g for 10 min at 4 °C.
The supernatant was digested with proteinase K and then extracted
twice with phenol-chloroform/isoamyl alcohol (24:1). The aqueous
phase, containing soluble DNA, was recovered and nucleic acids were
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washed with 70% ethanol, air-dried and dissolved in TE buffer (10 mM
Tris–HCl, 1 mM EDTA, pH 7.5). After digestion with RNase A (50 ng/ml
at 37 °C for 30 min), the sample was subjected to electrophoresis in a
1.8% agarose gel and visualized by ethidium bromide staining. Soluble
DNA from equal numbers of cells was loaded in each lane.
2.8. Polarographic measurements
O2 consumption was measured polarographically by means of
a Gilson 5/6 oxygraph using a Clark electrode, as in [16,17]. In order to
detect polarographically the cytochrome c (cyt c) presence in the
extramitochondrial phase, the capability of cell homogenate to oxidize
ascorbate (ASC) was checked [28 and the references therein]. Instru-
ment sensitivity was such as to allow rates of O2 uptake as low as
0.5 natoms min−1 mg−1 protein to be followed. The cell homogenate
in PBS (about 0.2 mg protein) was incubated in a thermostated
(25 °C) water-jacketed glass vessel (ﬁnal volume equal to 1.5 ml).
2.9. Superoxide anion detection
Superoxide anion (O2−•) was detected, as in [29], according to the
Fe3+-cyt c method. The newly formed O2−• gave an increase in absor-
bance at 550 (ε550 nm = 37 mM−1 cm−1) measured using a Perkin-
Elmer LAMBDA-5 spectrophotometer equipped with a thermostated
holder. A calibration curve was made by using an O2−• producing system,
i.e. xanthine plus xanthine oxidase, and an O2−• detection system,
i.e. Fe3+-cyt c, that, in the presence of O2−•, gave Fe2+-cyt c with 1:1
stoichiometry.
2.10. Antioxidant enzyme activities
The activities of SOD and catalase were determined with the cell
homogenate (about 0.1 mg cell protein). Superoxide dismutase (SOD,
E.C.1.15.1.1) activity was measured by the inhibition of xanthine oxi-
dase/cyt c system reaction, as described in [24]. In this assay xanthine
oxidase, acting on xanthine in the presence of oxygen, generates super-
oxide anion, O2− which reduces cyt c, and this reduction is inhibited by
SOD. One enzymatic unit of superoxide dismutase is the amount of
enzyme required to inhibit the rate of reduction of cyt c by 50%: then
the activity of SOD is expressed as the % inhibition of the control reac-
tion. CGC homogenate was suspended at 25 °C in 1.5 ml PBS buffer in
the presence of Fe3+-cyt c (10 μM) plus xanthine (50 μM). The reaction
was startedwith xanthine oxidase addition and the absorbance increase
at 418 nm was monitored. Catalase (E.C.1.11.1.6) determination was
performed by a spectrophotometric assay based on the catalyzed
decomposition of H2O2 [for ref see 24]. The peroxide decomposition
rate is directly proportional to the enzyme activity. To determine the
catalase activity the cell homogenate was suspended at 25 °C in 1.5 ml
PBS buffer in a quartz cuvette. After reading the initial absorbance at
240 nm, 100 μl H2O2 (ﬁnal concentration 10 mM) was added and the
decrease in absorbance monitored. The slope of the absorbance vs.
time plot is directly proportional to the activity of the sample and is
expressed as ΔA240/min × 106 cells.
2.11. Glutathione disulﬁde (GSSG)/reduced glutathione (GSH) ratio
measurement
GSH or GSSG was assayed in the cell homogenate, according to
Akerboom and Sies [30]. Brieﬂy, GSH in the presence of methylglyoxal
(2 mM) and glyoxalase I (6 e.u.) was speciﬁcally converted into
S-lactoyl-GSH which could be monitored directly at 240 nm; GSSG
amountwas assayed in the same cuvette bymeasuring the stoichiometric
conversion of NADPH (10 μM) spectrophotometrically at 340 nm in the
presence of glutathione reductase (1 e.u.).2.12. Caspase-3 activity
Caspase activity was measured by using the Clontech ApoAlert
Caspase-3 Assay Kit (Takara Bio Group, Otsu, Shiga, Japan) following
manufacturer's instructions. DEVD-pNA was used as a colorimetric
substrate. The increase in protease activity was determined by the spec-
trophotometric detection at 405 nm of the chromophore p-nitroanilide
(pNA) after its cleavage by caspase-3 from the labeled caspase-3-speciﬁc
substrate (DEVD-pNA).
2.13. ADP/ATP carrier measurement
The cell homogenate (0.1mg protein), containing themitochondria,
was incubated at 25 °C in 2 ml of standard medium consisting of
200 mM sucrose, 10 mM KCl, 1 mM MgCl2, and 20 mM HEPES–Tris
pH 7.2. Appearance of ATP in the extramitochondrial phase, due to ex-
ternally added ADP, was revealed as in [28,31,32], by using the ATP de-
tecting system (ATP D.S.) consisting of glucose (2.5 mM), hexokinase
(HK, 0.5 e.u.), glucose-6-phosphate dehydrogenase (G-6-PDH, 0.5 e.u.)
and NADP+ (0.2 mM) in the presence of P1,P5-Di(adenosine-5′)penta-
phosphate (Ap5A), a speciﬁc inhibitor of adenylate kinase [for ref see
32]. The rate of NADP+ reduction in the extramitochondrial phase was
followed as absorbance increase at 334 nm, measured as the tangent to
the initial part of the progress curve and expressed as nmol NADP+ re-
duced/min×mg cell protein. Control experiments were carried out in
the presence of ATR to ensure that the ADP/ATP exchange was mediated
by the ADP/ATP carrier [see 32,33].
2.14. Measurement of the mitochondrial permeability transition
pore opening
To visualize onset ofmPT eithermitochondrial swelling or adenylate
kinase (ADK) release from the mitochondria was monitored, as in [17].
Mitochondrial swelling was monitored at 25 °C by following the absor-
bance decrease at 546 nm. The cell homogenatewas suspended in ame-
dium containing 250mMsucrose, 2mMHEPES pH7.4, 0.5mMK2HPO4,
1 μM oligomycin, 2 μM rotenone and 5 mM succinate. ADK releasewas
monitored by assaying ADK activity at 25 °C, essentially as reported
above, in post-mitochondrial supernatant of both control and S-K5
cells (about 30 × 106 cells/1 ml), obtained after homogenization in
PBS and centrifugation at 15,000 ×g for 15 min.
2.15. Measurement of levels of both adenine nucleotides and AMP
breakdown products
Concentrations of intracellular phosphorylated adenine nucleosides
(ATP, ADP and AMP) and of AMP breakdown product, i.e. ADO, in
neuronal extracts were determined by HPLC as previously described
[28,34]. After 7 days in vitro, 6 × 106 CGCs were switched to high K+
serum-free (S-K25) medium and incubated in the same medium for
1 h. After the incubation the cell monolayer was washed twice with
2 ml phosphate buffered saline (PBS, 120 mM NaCl, 2.7 mM KCl,
10 mM phosphate buffer, pH 7.4). The cells were gently scraped off
the plate with PBS and collected in a ﬁnal volume of 1.4ml. The cell sus-
pension was immediately centrifuged at 2000 ×g for 5 min at 4 °C and
the cell pellet, strictly ‘dried out’ with a stick of blotting paper, was re-
suspended in a ﬁnal volume of 1.4 ml. This treatment was repeated
two times. As a control, ADP was assayed in the supernatants – by
means of a NADH enzyme-linked assay, i.e. Pyruvate kinase + Lactate
dehydrogenase coupled reactions [see 35] – in order to verify that the
washing procedure was able to remove all traces of the externally
addedADP,which– if present–would invalidate the outcomeof the ex-
periment. Cell pellets were immediately subjected to acid extraction by
adding 70 μl of ice-cooled 0.5MHClO4, vigorous shaking and incubation
for 20 min in an ice bath. The acid extract was immediately frozen in
liquid nitrogen and stored at−20 °Cuntil the neutralization. The frozen
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precipitate insoluble macromolecules; the supernatant (70–80 μl) was
neutralized by 4/5 volume 0.5 M KOH plus 1/5 volume 1 M KH2PO4,
pH 7.5, and left for 10–15min on ice. The potassium perchlorate precip-
itate was ﬁnally removed by centrifugation (17,900 ×g for 15 min at
4 °C). The neutralized supernatant was either analyzed immediately
or stored at−20 °C.
Results were expressed as nmol/mg cell protein. ADP (1mM), in the
absence or presence of different compounds (see legend to ﬁgure),
when present, was added to the serum-free BME (see above) simulta-
neously with induction of apoptosis.
2.16. Statistical analysis and computing
All statistical analyses in this study were performed by SPSS soft-
ware. The datawere representative of at least three independent neuro-
nal preparations (with comparable results) each one in independent
measurements (in each ﬁgure legend the number of measurements is
reported) and are reported as the mean with the standard deviation
(S.D.). Statistical signiﬁcance of the data was evaluated using the one-
way analysis of variance (ANOVA) followed by post-hoc Bonferroni
test. p b 0.05 was considered as signiﬁcant for all analyses.
Experimental plots were obtained using GraFit (Erithacus software).
3. Results
3.1. ADP prevents low-K+ induced CGC apoptosis
Prior to investigating the mechanism responsible for the ADP-
dependent prevention of apoptosis, we veriﬁed that ADP can rescue
CGCs from death (see Materials and methods section), according to
[14,18].
To this aim, 7 DIV neuron cultureswere kept either in high potassium
medium (S-K25 cells) or subjected to low potassium shift (S-K5 cells),
which is responsible of triggering apoptosis [for ref see 15,24], in the
absence or presence of ADP. That neurons died via apoptosis (Fig. 1)
was conﬁrmed by monitoring DNA laddering, which is a speciﬁc hall-
mark of apoptosis, and by the sensitivity of death to Act D. As shown in
Fig. 1A, DNA laddering at 15 h after apoptosis induction occurs in S-K5
cells (lane c), but not in S-K25 (lane b), and, in agreement with [15], it
was completely preserved in the presence of Act D (1 μg/ml) (lane e)
[see 24]. In Fig. 1B, we conﬁrmed that death occurred via apoptosis in
S-K5 cells where survival was reduced by 60% (p b 0.001, six experi-
ments) with respect to the control, at 24 h after potassium shift, in fairly
good agreement with [15,17] and as shown by its complete prevention
by Act D (1 μg/ml) (see [15]). Consistently, MK801 (1 μM), a selective
NMDA receptor antagonist, which prevents glutamate-dependent
necrosis, failed to rescue neurons (not shown).
ADP (0.01–1mM)was proven to prevent death in a dose-dependent
manner (Fig. 1C). The maximum protection was achieved in the pres-
ence of 1 mM ADP with an increase in cell survival up to about 90%
(p b 0.001, 6 experiments) with respect to the 42% obtained in S-K5
samples. The choice of using ADP at a concentration equal to 1 mM in
the forthcoming experiments was dictated by the fact that enzymes
consuming ADP have a low afﬁnity for ADP [36], and that this concen-
tration, giving the largest protective effect, makes possible to highlight
all differences, including the less signiﬁcant, in the experiments in
which use was made of compounds which prevent the ADP-mediated
protection (see below). Consistently, ADP (1mM), added to cell culture
simultaneously with induction of apoptosis, completely prevented DNA
laddering (Fig. 1A, lane d) as well as cell death (Fig. 1B). As a control, it
was veriﬁed that a similar behavior is achieved in the presence of
z-VAD (Fig. 1B), as already reported [24,37].
Interestingly, when ADP (1 mM) was added to cell culture at differ-
ent times after induction of apoptosis with cell viability estimated at
48 h, the extent of cell survival varied depending on the time of ADPaddition (Fig. 1D). Almost complete prevention of cell death occurs
when ADP was added within the ﬁrst 3 h after apoptotic stimulus
administration, i.e. when maximum ATP level together with maximum
increase of ROS production, AOX system activity and cyt c release
was detected [24,34]. At 5 h, i.e. when both caspase activation and
mitochondrial permeability transition pore (mPTP) opening start [17],
and later at 8 h, under condition in which mitochondria uncoupling
and caspase(s) activation are complete, ADP-mediated protection was
strongly reduced and totally exhausted, respectively.
3.2. ADP effect on some mitochondria-linked steps in the process of
CGC apoptosis
Having conﬁrmed that ADP prevents apoptosis of CGCs, its effect on
somemitochondria-linked steps in the process leading to apoptosis was
further investigated. Brieﬂy, we have already shown that in early apo-
ptosis (0–3 h after induction) the rate of glucose oxidation decreases
[16], the mitochondria are subjected to time-dependent uncoupling
[16] and elevated production of ROS occurs [24,37]. Cyt c is released
from the mitochondria while still coupled [37,38] and an increase in
the ATP level occurs [34]. In late apoptosis (3–8 h after induction) –
when the ROS level reaches steady state and ATP declines up to control
levels – there is cyt c-dependent caspase(s) activation, the proteasome-
and caspase(s)-dependent degradation of antioxidant system (AOS) as
well as caspase(s)-dependent degradation of the released cytochrome c
occur [24,37,38], and impairment of the adenine nucleotide translocator
(ANT-1) takes place, with ANT-1 becoming a component of the mPTP
[17].
3.2.1. Mitochondrial coupling in ADP–S-K5 cells
The ability of ADP (1 mM) to prevent impairment of mitochondrial
function, which occurs in early apoptosis [16], was investigated by
using the homogenates of either S-K25 or S-K5 CGCs, cultured in the
absence or presence of ADP for 3 h (Fig. 2A). To achieve this, oxygen
uptake was measured arising from the addition of succinate (SUCC)
to the cell homogenate in either the absence (state 2) or presence
(state 3) of ADP (1 mM) used to stimulate oxidation. The RCR values
(oxygen uptake in state 3) / (oxygen uptake rate in state 2)which reﬂect
the ability of the mitochondria to produce ATP, were about 5.1, 2.6 and
5,1 for S-K25, 3h-S-K5 and ADP–3h-S-K5 cells, respectively. When SOD
(50 U/ml) was added to 3h-S-K5 cell culture, the RCR value was 4.5
(inset to Fig. 2A), in good accordancewith [16]. Notice that i) the oxygen
consumption rate remained constant in S-K25 CGCs up to 3 h; ii) the
rate of oxygen uptake in state 2was not changed by treatment of culture
cells with ADP, ruling out the possibility that this compound can uncou-
ple the mitochondria.
3.2.2. Superoxide anion production and AOX system activity in ADP–S-K5
cells
Having established that ADPprotects themitochondria from theK+-
shift-dependent early uncoupling (see above), the ADP effect on other
mitochondrial steps was investigated separately at the times of 3 h
and/or 5 h after apoptosis induction, which reﬂect the early and the
late phases of apoptosis, respectively (see [24]). In order to individuate
the mechanism underlying the antiapoptotic action of the ADP, the
experiments were performed in the absence or presence of a variety of
compounds, such as purine receptor antagonist and/or ectonucleotidase
and nucleoside transporter inhibitors.
In CGC apoptosis, ROS extra-production takes place [24,39 and the
references therein] with all the apoptotic steps beingmostly dependent
on ROS level. Since the antiapoptotic effect of ADP could be achieved via
inhibition of ROS production and/or activation of AOX enzymes, as
suggested in [14,18], we investigated the effect of ADP on: i) O2−• level
at 3 h apoptosis, when maximum superoxide detection occurs [see 24]
(Fig. 2B) and ii) activity of AOX enzymes at 3 h apoptosis, when the
maximum increase of enzyme activity takes place [24] (Fig. 2C).
Fig. 1.DNA fragmentation and sensitivity of cell survival to ADP in cells undergoing apoptosis. (A)DNA fragmentation. SolubleDNAwas extracted fromeither neurones switched to serum-
free culturemedium containing low K+ (5mM) in the absence (lane c) or presence of ADP (1mM, lane d) or actinomycin D (Act D, 1 μg/ml; lane e). Lane b contains DNA from control cells
maintained in highK+ (25mM) for the same apoptosis induction time, i.e. 15 h.DNA from equal numbers of plated cells (6 × 106)was loaded in each lane. SizemarkerwasHaeIII-digested
ΦX174 phage DNA (lane a). (B–E) Cell survival. In B), cells were switched to serum-free medium containing low K+ in the absence (S-K5) or presence of ADP (1mM). At different times,
cell viabilitywasdeterminedby counting thenumber of intact nuclei. In C), ADP (0.01–1mM)was added to cell culture simultaneouslywith the shift to low [K+] and, 48h later, viable cells
were counted and compared to controls (% of Control). In D), ADP (1 mM) was added to cell culture at different times after apoptosis induction and cell viability estimated at 48 h. In E),
ADP (1mM)was added to culture cells at 2 times: i) t = 0, i.e. simultaneously with the shift to low [K+] and ii) t + 3 h, i.e. 3 h after apoptosis induction, when ADP is still able to protect
cells from death (see above, panel D). Atractyloside, when present, was added at a concentration equal to 10 μM. Cell viability is expressed as the percentage of S-K25 cells to which a 100%
valuewas given. Control valueswere 100±5. Results aremeans± standard deviations (S.D.) of triplicatemeasurements and representative of four different experiments carried outwith
different cell preparations from different groups of animals. Statistical analysis was by ANOVA and Bonferroni test: *p b 0.01, **p b 0.001 when comparing all samples (clear lines) with
each other; §p b 0.01, §p b 0.001 when comparing all samples (shaded lines) with each other. The lack of asterisk indicates no statistically signiﬁcant differences.
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in CGCs undergoing apoptosis (S-K5) with about 4 nmol/106 cells
(p b 0.0001, 4 exps), in agreement with [24], was strongly decreased
(up to 2 nmol/106 cells) by the externally added ADP in S-K5 cells. As
expected [29,40], treatment with SOD was found to partially prevent
O2−• appearance (not shown). The ADP effect on O2−• level was almost
completely prevented by 100 μM PPADS, a novel functionally selective
antagonist of purine receptor [41], thus indicating that O2−• levelmodulation by ADP was strictly dependent on its interaction with
receptor/s, as also suggested in [14,18].
Then, the effect of ADP on the activity of AOX enzymes was
measured and reported in Fig. 2C as percentage of the activity found
in S-K5 cells, taken as a control and to which a value of 100 was given.
In ADP-treated S-K5 cells, 3 h after potassium shift, the activities
of both SOD (136%) and catalase (124%) further increase while a
consistent reduction of the GSSG/GSH ratio (62%), which is an index of
Fig. 2.Mitochondrial coupling, superoxide anion production and AOX system activity in
ADP–S-K5 cells. (A) Mitochondrial coupling. Rat CGCs (2 × 106/well) at 7 DIV, switched
from high potassium (25 mM) (S-K25) to low potassium (5 mM) serum-free culture
medium in the absence (S-K5) or presence of 1mMADP (ADP–S-K5) for 3 h,were homog-
enized and incubated (0.2 mg cell protein) at 25 °C in a water-jacketed glass vessel and
the consumption of O2 was monitored polarographically. Succinate (SUCC, 5 mM) and
ADP (1 mM) were added at the indicated times. In the inset, S-K5 cells were treated
with SOD (50 U/ml) (SOD–S-K5). Numbers along the curves are rates of oxygen uptake
expressed as natom O/min×mg cell protein. (B) Superoxide anion production. Rat CGCs
(0.5× 106/well) at 7 DIVwere incubated either in high potassium(S-K25) or in lowpotas-
sium (S-K5) serum-free culture medium added with Fe3+-cyt c (10 μM) in the absence or
presence of ADP (1 mM). Where present, pyridoxalphosphate-6-azophenyl-2′,4′-
disulfonic acid (PPADS, 100 μM), was added simultaneously with ADP. At different times
after apoptosis induction, the culture solution was taken and the increase in absorbance
at 550 nm, due to Fe2+-cyt c formation, was determined. The experimental data are
reported as nanomol ROS formed ± S.D./106 cells, calculated on the basis of the stoichi-
ometry of the reaction using the extinction coefﬁcient determinedunder our experimental
conditions (see Materials and methods). The experiment was repeated four times with
different cell preparations. (C) Antioxidant system activity and GSSG/GSH ratio. Rat
CGCs (2 × 106/well) at 7 DIV were incubated either in high potassium (S-K25) or in low
potassium (S-K5) serum-free culture medium in the absence or presence of 1 mM ADP.
Where present, pyridoxalphosphate-6-azophenyl-2′,4′-disulfonic acid (PPADS, 100 μM),
was added simultaneously with ADP. At 3 h after apoptosis induction, cells were scraped,
collected, homogenized and assayed for SOD, catalase and GSSG/GSH ratio (see Materials
andmethods). Each value represents themean± S.D. value of antioxidant system activity,
expressed as percentage inhibition of Fe3+-cyt c reduction rate for SOD and as ΔA240/min
for catalase, and of [GSSG]/[GSH] ratio value (see Materials and methods), obtained from
ﬁve separate experiments carried out using different cell preparations. Values within the
brackets indicate the percentage of increase/decrease with respect to S-K5 cells alone to
which a value equal to 100 was given.
1343A. Bobba et al. / Biochimica et Biophysica Acta 1837 (2014) 1338–1349oxidative stress, was found. PPADS –which is without a direct effect on
the AOX activities – strongly prevented the ADP-dependent activation
of the cell AOX system in vivo.3.2.3. The release of cytochrome c from the mitochondria and the caspase-3
activation in ADP–S-K5 cells
Since in CGC apoptosis, ROS production causes the release of cyt c
from themitochondria [for refs see 40,42] which, in its new cytoplasmic
location, induces caspase activation by intervening in the formation
of the apoptosome [for ref see 24], we investigated if the cyt c release
is affected by ADP-treatment and hence if this compound inﬂuences
the activation of caspase-3. To do this, as in [38,40], we turned to polar-
ographic measurement of the activation of cyt c-dependent ASC oxida-
tion,which itself conﬁrmed that cyt cwas released in an active form [38]
(for details see the Materials and methods). In a typical experiment
S-K25, S-K5 or ADP–S-K5 cells, at 3 h after apoptosis induction (time
at which the maximum release of cyt c occurs), were compared to one
another with respect to their ability to oxidize externally added ASC
(5mM) (Fig. 3A). No oxygen uptake was found in the S-K25 cell sample
in the presence of ASC alone (trace a), showing both that themitochon-
dria were intact and that no release of cyt c had occurred. ASC addition
to homogenates from S-K5 or ADP–S-K5 CGCs resulted in oxygen
uptake at a rate of about 17 and 8 natom O/min×mg cell protein,
respectively (traces b–c), thus showing that ADP is able to prevent
the release of cyt c by about 50%. As a control (Fig. 3A, column chart),
externally added SOD (6.5 ± 1.2 natom O/min×mg cell protein) was
able to strongly prevent the release of cyt c as already reported [24].
When caspase-3 activity was measured at 8 h, time at which the
maximum of activity was reached [37], a decrease of about 55%was ob-
tained in the presence of ADP (0.085 a.u., p b 0.001, 5 experiments)
with respect to S-K5 cells (0.17 a.u.) (Fig. 3B). As a control, we
checked that ADP had no effect on the caspase activity in vitro, which
instead is strongly inhibited by z-VAD and only partially by SOD (not
shown).
3.2.4. ANT-1 activity, mPTP opening and ATP level in ADP–S-K5 cells
ATP is required for apoptosis to occur [43–45]. In early apoptosis,
ATP is mostly produced in the mitochondria by oxidative phosphoryla-
tion [34] and is exported via the ANT-1 into the cytoplasm (for refs see
[33]). The effect of ADP on the process that, starting with alteration of
ANT-1, leads to the opening ofmPTP [see above and 17]was investigated
by measuring in parallel both ANT-1-mediated transport and the mPTP
opening in S-K25, S-K5 and ADP–S-K5 cell homogenates (Fig. 4). Assays
were carried out both at 3 h, when it was shown that ANT-1 function is
impaired due to ROS, but nomPTP opening occurs, and at 5 h, when fur-
ther caspase(s)-dependent ANT-1 impairment occurs andmPTP opening
initiates [17]. When indicated, 1 mM ADP was added to the plate,
i.e. ADP–S-K5. Since ADP itself might affect the outcome of the experi-
ment, great care has been employed in the removal of ADP-containing
media at the end of the incubation time bymeans of a thoroughwashing
of the layer of adherent cells and replacingwith freshmedia. Tomeasure
the ANT-1 mediated transport, we resorted to a procedure (see [17])
that allows for the continuous monitoring of ATP efﬂux from the
mitochondria incubatedwith ADPwhilemPTP openingwas investigated
as mitochondrial swelling, as in [17] (for details see Materials and
methods), or as adenylate kinase (ADK) release. In a typical experiment
cell homogenates were treated with AP5A to inhibit adenylate kinase. In
all cases the ATP concentration outside the mitochondria was negligible
as no increase in the absorbance measured at 334 nm was found in the
presence of the ATP D.S. As a result of addition of ADP (0.04 mM), an
increase in the NADPH absorbancewas found, indicating the appearance
of ATP in the extramitochondrial phase. The explanation for this is as
follows: ADP enters the mitochondria in exchange for endogenous
ATP; inside the matrix ATP is synthesized by oxidative phosphorylation,
and the newly synthesized ATP exits the mitochondria in exchange for
further ADP via the ANT-1. That the rate of NADPH formation mirrored
in all cases the rate of ADP/ATP exchange was conﬁrmed by applying
control ﬂux analysis, as in [17] (not shown). The rates of ATP efﬂux
were 10.8, 2.9 and 1.7 nmol NADP+ reduced/min×mg cell protein for
S-K25, 3h-S-K5 and 5h-S-K5 CGCs respectively (Fig. 4A–B). When SOD
Fig. 3. Cytochrome c release from mitochondria and caspase-3 activation in ADP–S-K5 cells. (A) Cytochrome c release. Rat CGCs (2 × 106/well) at 7 DIV were incubated in either high
potassium(S-K25) or lowpotassium serum-free culturemedium in the absence (S-K5) or presence of 1mMADP (ADP–S-K5) or 50U/ml SOD (SOD–S-K5). At 3 h after apoptosis induction,
the cells were scraped, collected and homogenized. Cell homogenate (about 0.2 mg protein) was incubated at 25 °C in the presence of 3 μM rotenone, 0.8 μM antimycin and 6 μM
myxothiazol in a water-jacketed glass vessel. Results, expressed as natoms O/min×mg cell protein, are the means ± S.D. of triplicate measurements and are representative of at least
ﬁve different experiments carried out with different cell preparations obtained from different groups of animals (on the right). ANOVA and Bonferroni test: **,*** statistically signiﬁcantly
differentwith p b 0.01 and p b 0.001, respectively,when S-K5 cellswere compared against the samples indicatedwith asterisk/s. (B) Caspase-3 activity. Cells (6× 106/well)were incubated
either in high potassium (S-K25) or in low potassium (S-K5) serum-free culturemedium in the absence or presence of ADP (1mM). At 8 h, cultureswere lysed and assayed for DEVD-pNA
cleavage. The increase in protease activity was determined by the spectrophotometric detection, at 405 nm, of the cleaved chromophore p-nitroanilide (pNA). Each value represents the
mean ± S.D. values of DEVD-pNA cleavage, expressed as A405 value. The experiments were repeated ﬁve times. ADP/z-VAD in vitro indicates the effect of ADP or z-VAD (100 μM) on the
caspase activity in vitro.
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ANT-1 impairment was found at 3 h after apoptosis induction (10.2
nmol NADP+ reduced/min×mg cell); this conﬁrmed that the decrease
in ANT-1 efﬁciency depended on extra ROS production, in accordance
with [17]. As expected, in 5h-S-K5 cells, where a progressive impairment
in ANT-1 occursmainly due to caspase(s) activation, the SOD prevention
decreased to 6.1 nmol NADP+ reduced/min×mg cell. In ADP–3h-S-K5
and ADP–5h-S-K5, the rates of ATP efﬂux were 10.6 and 10.7 nmol
NADP+ reduced/min×mg cell protein respectively (Fig. 4A–B). This
shows that ADP completely prevents ANT impairment, not only at 3 h,
as SOD does, but also surprisingly at 5 h. In a parallel experiment
(Fig. 4C), mPTP opening was measured by monitoring mitochondrial
swelling, as a change in absorbance at 546 nm of the CGC homogenate
(seeMaterials andmethods section). It should benoted that the decrease
in light absorbance is a spontaneous process due to apoptosis and is not
calcium-dependent. No mPTP opening was found at 3 h after induction
of apoptosis (not shown), in accordance with [17]. In 5h-S-K5-CGCs,
mPTP opening occurred which was fully prevented in the presence
of 1 μM cyclosporine A (CsA), an inhibitor of mPTP [17,46]. In both
SOD- and ADP–S-K5 cells, a decrease in both the rate and extent of
mPTP opening was found (80 and 70%, respectively).
In the graphs reported in Fig. 4D, both ADP/ATP exchange (on the
left) and mPTP opening (on the right), measured as ADK release intothe extramitochondrial phase, were investigated as a function of time
(0–8 h) of apoptosis. In early apoptosis (S-K5), up to 3 h, the rate of
ADP/ATP exchange decreased gradually as compared to control cells
(S-K25),which instead remained constant all over the time,with inhibi-
tion increasing with progression of apoptosis (about 55% inhibition
found at 3 h, p b 0.001), essentially as in [17]; in the same time range,
no or negligible mPTP opening was found in either S-K25 or S-K5 cell
homogenates. In late apoptosis, between 3 and 8 h, a further decrease
in the ADP/ATP exchange was found with about 10% residual ANT-
dependent transport detected at 8 h. mPTP opening occurred progres-
sively over the 3–8 h time range in S-K5 cells, conﬁrming that during
late apoptosis both a further decrease in the ANT-1 transport function
and mPTP opening occur. Surprisingly, while SOD, externally added to
S-K5 cells, was found to fully prevent ANT-1 impairment in the early
apoptosis and only partially in the late stage up to 8 h, a complete pre-
vention of ANT-1 impairment was observed in the presence of ADP
throughout the considered time range, i.e. 0–8 h, suggesting that
the decrease in ANT-1 efﬁciency also depends on other process/es in
addition to the ROS-dependent ones, i.e. the receptor-dependent AOX
enzyme activation (see Fig. 2C). Otherwise, no mPTP opening in the
presence of either SOD or ADP was found in early apoptosis, showing
that ROS cannot themselves cause mPT, which occurred only in the
3–8 h time range, although to a lesser extent than with S-K5 cells.
Fig. 4. ANT-1 activity and mPTP opening in ADP–S-K5 cells. (A–B) ANT-1 activity. Appearance of ATP due to the addition of ADP (0.04 mM) to CGC homogenate (0.1 mg protein) from
S-K25 or S-K5 cells in the absence or presence of ADP (1 mM) (ADP–S-K5) or SOD (50 U/ml) (SOD–S-K5) at 3 (A) and 5 h (B) after apoptosis induction was monitored as described in
the method section (Section 2.13). C) mPTP opening. Rat CGCs (15 × 106/well) at 7 DIV were incubated either in high potassium (S-K25) or low potassium (S-K5) serum-free culture
medium in the absence or presence of ADP (1 mM) or SOD (50 U/ml) at 5 h after apoptosis induction. mPTP opening was monitored by mitochondrial swelling (see Materials and
methods, Section 2.14). D) ADP/ATP exchange andmitochondrial permeability transition en route to apoptosis. Rat CGCs (15 × 106/well) at 7 DIVwere incubated either in high potassium
(S-K25) or in low potassium (S-K5) serum-free culture medium in the absence or presence of ADP (1 mM) (ADP–S-K5) or SOD (50 U/ml) (SOD–S-K5). At different times after apoptosis
induction ADP/ATP exchange and mPTP formation en route to apoptosis were measured as in A) and by monitoring the adenylate kinase (ADK) release frommitochondria, respectively.
Reported values are themean of four independent neuronal preparations (with comparable results) each one in triplicate with the standard deviation. Statistical analysis was by ANOVA
and Bonferroni test. ADP/ATP exchange: for S-K25 there were no statistically signiﬁcant differences when comparing all the samples with each other in the whole time range; p b 0.001
when comparing S-K25/ADP–S-K5 vs S-K5 in thewhole time rage; p b 0.05when comparing S-K25/ADP–S-K5 vs SOD–S-K5 in the 3–8 h time range.Mitochondrial permeability transition:
p b 0.001 when comparing each S-K25 vs S-K5; p b 0.01 when comparing S-K25/S-K5 vs ADP–S-K5/SOD–S-K5 in the 3–8 h time range.
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ADP on the mitochondrial translocator (Fig. 4D), and in order to having
more clues on the ADP protective effect on cell processes, i.e. to clarify if
it is only due to receptor-dependent antioxidant enzyme activation, as
suggested in Fig. 2B,C, or if it also involves some strategicmitochondrial
protein/s, such as ANT-1, we resorted to the use of ATR, a membrane-
impermeant inhibitor of ANT which binds to the translocator from the
cytosolic side with very high afﬁnity [47]. The effect of ATR on cell via-
bility was evaluated (Fig. 1E) by adding this compound to CGCs during
apoptotic treatment, either in the absence or in the presence of ADP,
under two experimental conditions: simultaneously with the apoptotic
shift to low [K+], lines 3 and 4 respectively, or after 3 h (lines 6 and 8),
i.e. when the ADP is still able to protect cells from death (see above,
Fig. 1D). No effect on cell viability was observed with respect to S-K5
sample (line 1) when ATRwas incubatedwith S-K5 cells either simulta-
neously (line 3) or 3 h after the apoptosis induction (line 6). On the
other hand, i) if ATR was added at time zero, both in the presence of
ADP (line 4) and 3 h before ADP addition (line 7), partial prevention
of ADP protection was observed (compare 56 and 48% with the
90% achieved in S-K5 + ADP sample, respectively); ii) if ATR was
added 3 h after ADP addition (line 8) almost complete protection by
ADPwas conﬁrmed (about 80%, compare lines 5 and 8), thus suggestingthat the ADP-mediated cell protection is in part due to the ADP-binding
to ANT-1. Act D, used as a control, completely prevents death (line 9).
These last results, more than others, raise the question whether the
ADP effect ismediated only by its interactionwith a cell purine receptor,
or is also the consequence of its internalization into the cell. In the latter
hypothesis, the ADP uptake into the cell can occur i) directly or ii) with a
stepwise process consisting of ADP hydrolysis by means of plasma
membrane nucleotide metabolizing enzymes, ADO uptake and ﬁnally
resynthesis into the cell. To provide clues on this issue, the intracellular
levels of ADP, ATP, AMP and ADO were measured by HPLC in the
neutralized perchloric acid extracts of S-K25-CGCs incubated with
ADP, in the absence or presence of the antagonist of purine receptor
(PPADS), the inhibitor of ectonucleotidase (AMPCP) and the inhibitor
of nucleoside transporter (NBMPR).
The results shown in Fig. 5 suggest that ADP internalization into cells
also occurs. The intracellular levels of ATP, ADP, AMP and ADO in S-K25
cells, reported in the No Addition bars, were found to be 1, 1, 0.4 and
0.15 nmol/mg cell protein respectively, essentially as in [34]. These
levels signiﬁcantly increased when S-K25 cells were incubated with
1 mM ADP ranging from 25% in the case of ATP (°p b 0.05, +ADP with
respect to No Addition) up to 180% in the case of ADO (°p b 0.001,
+ADP with respect to No Addition). It should be noted that the
Fig. 5. ATP level in ADP–S-K25 cells. The amounts of ATP were measured by HPLC in
neutralized perchloric acid extracts of S-K25 in the absence (No Addition) or presence of
ADP (1 mM), added either alone (+ADP) or together with PPADS (100 μM), AMPCPX
(100 μM), NBMPR (2 μM). ANOVA and Bonferroni test: °p b 0.05, °° p b 0.001 when
comparing +ADP sample to S-K25 cells (No Addition); *, **, *** statistically signiﬁcantly
different with p b 0.05, p b 0.01 and p b 0.001 with respect to +ADP sample cells. The
lack of asterisk indicates no statistically signiﬁcant differences.
Table 1
ADP effect on Abeta- or tau fragment-dependent ANT-1 impairment.
Line Sample Added peptide ADP V (% of S-K25)
1 S-K25 – ADP 100
2 ADP–S-K25 – ADP 101
3 S-K25 NH2htau ADP 20**
4 ADP–S-K25 NH2htau ADP 96
5 S-K25 A-beta ADP 77*
6 ADP–S-K25 A-beta ADP 73§
7 S-K25 A-beta + NH2htau ADP 14**
8 ADP–S-K25 A-beta + NH2htau ADP 75§
Rat CGCs (15 ×106/well) at 7 DIV were incubated in high potassium (S-K25) culture
medium in the absence (clear lines) or presence of ADP (1 mM) (shaded lines). The ADP ex-
posurewas terminated by removing the compound-containingmedia, followed bywashing
twice and replacing with freshmedia. Cell homogenates (0.1 mg protein), containing mito-
chondria, were incubated, at 25 °C, with either NH2htau or Aβ1–42, at a concentration equal
to 1 and 2 μM respectively, for 3 min, after which the suspension was centrifuged and the
pellet, resuspended in 2.0 ml of standard medium (see Materials and methods), was incu-
bated with the ATP detection system. NADPH formation was monitored after ADP addition,
as described in themethod section (Section 2.13). The reaction rate is expressed as percent-
age of S-K25 towhich a value of 100 is given. Values aremean± SD from four experiments,
carried out using different cell preparations. Statistical analysis was by ANOVA and
Bonferroni test: *p b 0.01, **p b 0.001 when comparing all the samples (clear lines) with
each other; §p b 0.01 when comparing all the samples (shaded lines) with each other.
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ual externally added ADP has been completely removed before carrying
out the measurements with HPLC (see Materials and methods for
details). A further increase of intracellular ATP (up to 55%) and ADP
(up to 80%) level occurs when S-K25 cells were treated with ADP in
the presence of PPADS (100 μM) which was without effect on AMP
and ADO amount. On the other hand, when AMPCP (100 μM) and
NBMPR (2 μM), ectonucleotidase and nucleoside transporter inhibitors
respectively [48,49], were added simultaneously with ADP to S-K25
cells, an almost complete prevention of the ADP-dependent intracellu-
lar increase of all the tested metabolites was observed and the levels
of ATP, ADP, AMP and ADO become roughly similar to those obtained
in S-K25 cells alone.
As a control, itwas veriﬁed that i) the inhibitors had no effect on cells
if ADP is not present (not shown) and ii) the ADP level was insigniﬁcant
in medium – after the washing and resuspension of the cells previously
treated with ADP – as veriﬁed by assaying ADP by means of a highly
sensitive enzymatic reaction (not shown).
3.3. ADP effect on Abeta- or tau fragment-dependent ANT-1 impairment
Evidences show that, in S-K5 conditions, an amyloidogenic
route early occurs in apoptotic CGCs in correlation with caspase(s)-
and calpain-mediated tau cleavage generating one or more toxic
NH2-derived tau fragments which further contributes to the ampliﬁca-
tion of neuronal demise [for refs see 31,50]. Recently we have proved
that two AD peptides – i.e. Aβ1–42 and the smaller tau peptide
NH2-26–44 (namedNH2htau) – added to CGChomogenate, individually
inhibited the ANT-1 in a non-competitive and competitive manner, re-
spectively, and together aggravated the mitochondrial dysfunction byexacerbating the ANT-1 impairment, thus leading to dysfunction in en-
ergy metabolism prior to induction of cell death [50,51]. Further, Aβ1–
42, added ﬁrst to the cell homogenate, was able to decrease the
inhibitory effect of NH2htau on ANT-1 activity.
In order to investigate on the capability of ADP to protect ANT-1
from the toxic ‘attack’ of the two AD peptides, cell homogenates were
prepared from S-K25 and ADP–S-K25 cells and the effect of Aβ1–42
and NH2htau, either added individually or together, on ANT-1 activity
was tested (Table 1). When either NH2htau (line 3) or Aβ1–42 (line
5) or both of them (line 7)were incubatedwith S-K25 cell homogenates
for 3 min, the reaction rates of ANT-1, expressed as percentage of the
S-K25 sample (line 1) to which a value of 100 was given, were found
to be 20, 77 and 14% respectively and essentially as in [32,50]. When
ADP-treated cells were used, no NH2htau inhibition was detected
(comparing lines 2 and 4) (101 vs 96%). On the contrary, about 25%
inhibition was conﬁrmed when either Aβ1–42 or NH2htau + Aβ1–42
was added to ADP-cells (lines 6 and 8, respectively). These ﬁndings
suggest that the lack of the inhibitory effect of NH2htau on ANT-1,
which occurred if cells were treated with ADP, is likely due to an
ADP-mediated protection of group/s involved – presumably at the
ANT-1 active site – in the interaction of NH2htau, but not of Aβ1–42
with ANT-1. The same applied to the effect of Aβ1–42 + NH2htau
(line 8), thus further conﬁrming that the rate of NADPH synthesis was
strictly dependent on the treatment of cells with ADP, regardless of
the interaction between Aβ and NH2htau and consistently with [50].4. Discussion
The starting point of this paper is that ADP can prevent low
potassium-dependent apoptosis in the cell model system of CGCs
(Fig. 1), conﬁrming its pro-survival effect and suggesting its use in
neuroprotection. The added value of this paper lies in the fact that, for
the ﬁrst time, it has been possible to propose a mechanism of action
which could explain, at the molecular level, the protective role of ADP
towards apoptosis, this by studying the effect of ADP on the various
apoptotic steps so far identiﬁed in the cell system herein employed
(i.e. CGCs) and conﬁrming that all the events,measured in thewhole cel-
lular context, respond in a consistent manner. Collectively our data are
consistent with results by others [12–14,19,52], which demonstrate a
cytoprotective action of adenosine during cell injuries, andwith the ﬁnd-
ing that adenosine and ADP exert a speciﬁc and marked antiapoptotic
action in cultured cerebellar granule cells [18]. On the other hand, the
1347A. Bobba et al. / Biochimica et Biophysica Acta 1837 (2014) 1338–1349presentwork is not in linewith previousﬁndings fromother cell systems
[53–60].
First of all it is noteworthy that, in the sameway in which the recov-
ery from apoptosis in CGCs is accompanied by a parallel block of the
functional impairment which occurs in certain steps of the mitochon-
drial pathway, so our results for the ﬁrst time provide evidence that
the effects of ADP involve mitochondria. Indeed several mitochondrial
processes which occur during CGC apoptosis, i.e. impairment of mito-
chondrial coupling (Fig. 2A), release of cyt c (Fig. 3A), ANT-1 alteration
and mPTP opening (Fig. 4), are prevented by ADP.
Moreover, as ADPwas able to decrease ROS levels (Fig. 2B), which is
in agreement with previous ﬁndings reporting that the ROS production
takes place early during apoptosis in this neuronal model being
upstream the mitochondrial pathway [16 and the references therein],
we strongly suggest that the prevention of apoptosis by ADP is at least
in part due to activation of the antioxidant enzymes.
Accordingly, we proved (Fig. 2C) that the up-regulation of antioxi-
dant systemactivity occurring in ADP–S-K5 cells is signiﬁcantly reduced
when the receptor antagonist PPADS was added. The ADP-dependent
fast increase in AOX activity comes in addition to the increase which
per sè occurs in CGCs undergoing apoptosis: we have reported that the
activity of SOD and catalase and the thiol oxidation state increase up
to 3 h, a time atwhich cells are still all alive even though ROS production
increases [see 24].
Furthermore, the ﬁnding that the ADP effect is mediated not only by
the activation of the cellular AOX enzymes, but also by the interaction of
ADP with the mitochondrial ANT-1, offers interesting clues of discussion.
In fact, it proposes for the ﬁrst time an internalization of ADP – as such or
after its degradation outside the cell and re-synthesis inside – which,
alongwith other purine base adenine, is present in vivo in the extracellu-
lar space and whose balance between release and removal by enzymatic
degradation is inﬂuenced by several physiological or pathological stimuli
[61–64].
The ADP internalization is clearly demonstrated by the results
shown in Fig. 5 – providing that the external addition of ADP to cell
culture causes an increase of intracellular ADP level as well as of its
derivative products (i.e. ATP, AMP and ADO) – which support the
hypothesis that ADP i) as such or ii) through its conversion to ADO,
passes from outside to inside the cell. The ﬁrst possibility is objected
by numerous papers in which the uptake of ADP in cell apparently
does not happen [65,66]. More evidences are in favor of the hypothesis
that ADP is hydrolyzed via ecto-5′-nucleotidases with extracellular
formation of adenosine which is subsequently re-uptaked via the
ADO transporter [61,62,67,68]. Consistently with this hypothesis, the
internalization process is sensitive to the antagonist of purine receptor
and the inhibitors of ectonucleotidase and nucleoside transporter (see
Fig. 5). Anyway, if ADP internalization is due to a direct ADP uptake
process into the cell – this hypothesizing an ADP translocator – or to a
metabolizing enzyme-dependent process remains to be established
through a detailed study which is not pertinent with the focus of this
paper. Unfortunately, at present we cannot still say which the real
neuroprotective molecule is: whether the ADP per se or one of its deg-
radation products. A more detailed work to clarify whether ADP exerts
the protective action independently of its degradation to adenosine in
the CGCs undergoing apoptosis is going to be addressed.
In Fig. 4, we show that, although ADP is essential to completely
protect mitochondrial ANT-1, its effect on mPTP opening is only partial,
thus suggesting that ANT-1 involvement is not the primary event
leading to mitochondrial permeabilization and then to cell death, con-
sistently with [17]. In this regard, a comparison made between loss of
ANT transport function andmPTP opening reveals that the two process-
es occur simultaneously in S-K5 cells, either in the absence or presence
of SOD, in the 5–8 h time range after apoptosis induction. This is not true
with ADP–S-K5 cells for which the reciprocal relationship holds only up
to 3 h but soon after the two processes follow separate paths supporting
the hypothesis of some authors [17,69] whereby mPTP opening isdispensable to cell death. Consistently, the data shown in this study,
i.e. the complete prevention of death, but the partial prevention of
mPTP opening by ADP, conﬁrm what we have previously suggested:
in CGC apoptosis, death and mPTP are not strictly dependent on each
other. There are two immediate feedbacks of these data: i) mPTP open-
ing does not only require ANT impairment, somehow conﬁrming what
was sensationally suggested by Kokoszka et al. [69], who, by using the
mitochondria from the liver of ANT knockout mice, observed that they
still possess mPTP activity; ii) mPTP opening does not result in death,
consistently with [17]. It is noteworthy, moreover, that in the light of
the inverse overlapping sensitivity of ANT andmPTP both to the caspase
inhibitor and to other inhibitors used to block cell systems participating
in apoptosis, and because no change occurs either in the amount or the
size of ANT, i.e. ANT itself was proved not to be the caspase target [17],
we conclude that although it is sure that a functional alteration of ANT
takes place resulting in ANT becoming a functional component of
the pore responsible for the mPT, the lack of overlapping sensitivity
of ANT and mPTP to ADP is probably due the failure of other proteins
participating in the pore formation, as suggested in [17], and/or to
other factor/s. The factor/s which can contribute to the prevention of
mPTP opening by ADP may be kinetic parameters, concentrations
of metabolite/s, exposure time to all those compounds/parameters,
and all those ones that – unlike experiments conducted on isolated
mitochondria from different organs, under speciﬁc and controlled ex-
perimental conditions [70–73] – cannot be kept under experimental
control in a whole cellular context.
Shifting the focus towards the effect of ATR on the viability
(see Fig. 1E), this selective ANT inhibitor prevents ADP protection,
thus suggesting that the molecular mechanism responsible for the
ADP protective effect is not unique. Since complete prevention of ADP
protection occurred only when ATR and PPADS are added together
(compare 29%, i.e. in the presence of PPADS + ATR, with 56%, in the
presence of ATR alone) it is inevitable to assume that the ADP protective
effect on cell death is mediated both by the activation of AOX system
(see above) and by its direct interaction with the mitochondrial carrier
that drives the ADP/ATP exchange. Nevertheless, it should also be con-
sidered that the activation of AOX enzymes results in depressed levels
of ROS which in turn reduces the ANT-1 activity, as in [17].
Besides, we have recently established [31,50] that extracellular ADP
protects ANT-1 from impairment produced by NH2htau fragment
which, either individually or even more when added together with
Aβ1–42, inhibits the mitochondrial translocator. The ADP capability to
protect the carrier from the toxic NH2htau can be easily explained
when considering that the inhibition exerted by this fragment on
ANT-1 is competitive-like, that is, it interacts with the catalytic site to
which the substrate binds. That ADP acts at the level of the catalytic
site is further conﬁrmed by data with ATR (Fig. 1E) and also by the
mPTP prevention, knowing that ADP binding to the ADP/ATP translocase
caused inhibition of the Ca2+-induced permeability transition of the
mitochondrial inner membrane [74,75].
Interestingly, it has been recently reported that the N-terminal
region of tau protein has a putative site for ATP/ADP binding and that
full-length tau is able to bind ATP. However, although the interaction
tau/ATP induces in vitro self-assembly of the protein, no tau self-
aggregation is found after incubation with ADP [76]. Therefore, it's
possible to speculate that adenosine nucleotides can play a role in mod-
ulating tau toxicity during in vivo neurodegeneration. The interaction
of tau with ATP not only could contribute to lower the cytosolic ATP
pool in neurons but also could potentiate its inhibitory effect on
ATP-producing mitochondria [77], which is in contrast blocked by
ADP. An alternative but not mutually exclusive action of ADP could
consist in restoring ATP levels which are generally reduced during apo-
ptosis in several in vitro cell systems [for ref see 34] as well as in aging
neurons and even more in Alzheimer's disease neurons [78]. However,
the possible biological signiﬁcance of this effect and of the mechanism
through which it is reached still remains to be fully investigated.
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antiapoptotic action of ADP, the restoration of Ca2+ homeostasis,
which was imbalanced by the Cai2+ drop caused by the potassium
withdrawal from culture medium [15], or the activation of alternative
pathway/s occurring downstream the Cai2+ drop, could of course be
considered. However, even though interesting, these topics fall outside
the scope of our work at present.
Another issue that the complete protection by ADP calls into
question – and on which there is a lot of discussion – is the ‘point of
no return’, a decisive regulatory event also termed ‘the commitment-
to-die’. This matter deserves special attention. Beyond the ‘point of no
return’, the fate of the cell, undergoing apoptosis, is irreversiblymarked:
several studies suggested that the ultimate determinant of cell death
could be the activation of caspase(s) [79–81], while others the loss of
mitochondrial membrane potential directly governed by a subset of
the BCL-2 family of proapoptotic proteins [82–84].
From the data of Fig. 1B, in which the viability at 48 h was evaluated
in the presence of ADP, added at different times after apoptosis induc-
tion, it appears clear that the maximum rescue time within which it is
possible to ﬂip the fate of CGCs shifted to 5 mM K+, is 3 h, that is
when the ROS reaches the highest level and the AOX activity increases
and cyt c release also occurs. It is important to notice that at this time,
i.e. 3 h, caspase(s) is/are not yet active and mitochondrial membrane
potential, which is early impaired [see 16,35] in apoptosis, can be recov-
ered by the released cyt c, which can generate protonmotive force and
drive ATP synthesis in the isolated mitochondria [36].
Throwing an arrow in favor of optimizing scientiﬁc research for
therapeutic purposes, it could be assessed that this type of research
brings close the possibility to block the degenerative process in an
early presymptomatic stage or in a phase in which the neurons can
still recover their functionality.
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